ReviewTherapeutic advances in hematology2021

The evolving role of Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia.

Max J Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.